Nuveen Asset Management, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Nuveen Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$0.28 - $1.16 $1.2 Million - $4.97 Million	-4,288,258 Reduced 99.38%	26,815 $8,000
Q1 2024 May 13, 2024	BUY	$1.06 - $1.67 $3,784 - $5,961	3,570 Added 0.08%	4,315,073 $5.01 Million
Q4 2023 Feb 14, 2024	BUY	$1.26 - $1.79 $335,023 - $475,946	265,892 Added 6.57%	4,311,503 $7.29 Million
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $734,076 - $1.16 Million	455,948 Added 12.7%	4,045,611 $7.32 Million
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.95 $772,103 - $1.32 Million	677,284 Added 23.26%	3,589,663 $6.68 Million
Q1 2023 May 15, 2023	BUY	$1.2 - $2.19 $874,615 - $1.6 Million	728,846 Added 33.38%	2,912,379 $3.87 Million
Q4 2022 Feb 14, 2023	SELL	$1.63 - $3.52 $1.06 Million - $2.29 Million	-651,879 Reduced 22.99%	2,183,533 $3.69 Million
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $904,605 - $4.63 Million	1,239,185 Added 77.63%	2,835,412 $8.85 Million
Q2 2022 Aug 15, 2022	BUY	$2.2 - $4.2 $3.51 Million - $6.7 Million	1,596,227 New	1,596,227 $3.8 Million

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.